Researchers identify a protein mechanism capable of actively burning fat and preventing new fat cell formation, opening potential obesity treatments.

A recent study suggests a key cause of ischemic strokes has been overlooked for decades, potentially changing diagnosis and treatment approaches.

Eyepoint Pharmaceuticals experiences a surge in international media coverage, with 25 mentions in recent reports, highlighting increased interest in the company.

Gavi’s recent board meeting reaffirmed commitment to respecting country sovereignty, addressing health system fragility, and strengthening health security worldwide.

Gavi commits to vaccinating 500 million additional children worldwide despite funding challenges, intensifying global immunization efforts.

Gavi has approved a $180 million fund to boost vaccine manufacturing capacity across Africa, aiming to improve local access and health resilience.